Agile Therapeutics Stock News

Gold Standard Ventures Corp (GSV) with the stream of 3.55% also noticed, India Agile Therapeutics, Inc. (AGRX) encountered a rapid change of -2.52% in the last hour of Fridays trading The post Traders cant brush off this: Gold Standard Ventures Corp (AMEX:GSV), Agile Therapeutics, Inc. (NASDAQ:AGRX) appeared first on Stocks Equity .

A contraceptive is a device or drug that avoids a woman from becoming pregnant. Some contraceptives avoid pregnancy by averting ovulation. A kind of birth control that works the best to prevent pregnancy is the insert and IUDs they''re also

Check these Under $1 penny stocks out for your watchlist The post Top Penny Stocks For Your Under $1 List Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com

Agile Therapeutics Inc. (NASDAQ:AGRX) traded at $0.57 at close of the session on Monday, 11/29/21, made an upward move of 3.52% on its previous days price. Looking at the stock we see that its previous close was $0.55 and the beta (5Y monthly) reads 1.02 with the days price range being $0.54 $0.5773. In Are Investors Keen On Selling Holdings In Agile Therapeutics Inc. (NASDAQ: AGRX)? Read More »

Agile Therapeutics, Inc. (AGRX) with the stream of 3.52% also noticed, India Venus Concept Inc. (VERO) encountered a rapid change of -1.46% in the last hour of Mondays trading session. The post Flashy Stock: Agile Therapeutics, Inc. (NASDAQ:AGRX), Venus Concept Inc. (NASDAQ:VERO) appeared first on Stocks Equity .

Royal Bank of Canada grew its stake in shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) by 6.5% during the second quarter, Holdings Channel reports. The institutional investor owned 994,071 shares of the specialty pharmaceutical companys stock after purchasing an additional 60,835 shares during the quarter. Royal Bank of Canadas holdings in Agile Therapeutics were worth $1,322,000 []

Agile Therapeutics, Inc. (AGRX) with the stream of -7.91% also noticed, India Ucommune International Ltd (UK) encountered a rapid change of -5.83% in the last hour of trading session. Agile The post Have an eye on: Agile Therapeutics, Inc. (NASDAQ:AGRX), Ucommune International Ltd (NASDAQ:UK) appeared first on Stocks Equity .

Agile Therapeutics, Inc. (AGRX) with the stream of -7.91% also noticed, India UpHealth, Inc. (UPH) encountered a rapid change of 0.00% in the last hour of Friday’s trading session. Agile … The post Stock’s Volume Buzz: Agile Therapeutics, Inc. (NASDAQ:AGRX), UpHealth, Inc. (NYSE:UPH) appeared first on Stocks Equity .

In the last trading session, 1.45 million shares of the Agile Therapeutics Inc. (NASDAQ:AGRX) were traded, and its beta was 0.94. Most recently the companys share price was $0.62, and it changed around -$0.03 or -4.44% from the last close, which brings the market valuation of the company to $78.96M. AGRX currently trades at a Agile Therapeutics Inc. (NASDAQ: AGRX): Historical Performance And Trend Read More »

Agile Therapeutics, Inc. (AGRX) with the stream of -4.44% also noticed, India Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT) encountered a rapid change of 0.67% in the last hour The post Stock Views And Recommendations: Agile Therapeutics, Inc. (NASDAQ:AGRX), Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) appeared first on Stocks Equity .

Equities analysts expect that Agile Therapeutics, Inc. (NASDAQ:AGRX) will post sales of $1.78 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Agile Therapeutics earnings. The lowest sales estimate is $1.70 million and the highest is $1.82 million. Agile Therapeutics reported sales of $750,000.00 in the same quarter last []

Boothbay Fund Management LLC purchased a new position in shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 29,757 shares of the specialty pharmaceutical companys stock, valued at approximately $40,000. A number of other large investors have also []

After trading down from $2.86/share to $.75/share so far this year, Agile's share price is reflecting worse-case scenario. Despite the market sell-off, Agile's business is actually ramping up.

Agile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q3 2021 Results - Earnings Call Transcript

Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET